Oric Pharmaceuticals, Inc. ORIC Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s other income (expense)?
- Oric Pharmaceuticals, Inc. (ORIC) reported other income (expense) of $3.85M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s other income (expense) changed year-over-year?
- Oric Pharmaceuticals, Inc.'s other income (expense) increased by 42.8% year-over-year, from $2.7M to $3.85M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s other income (expense) has grown at a 205.2% compound annual growth rate (CAGR), from $156K to $13.54M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.